Prohibits the expenditure of federal funds for payment or reimbursement for a drug prescribed for the treatment of erectile or sexual dysfunction, including under any federal health care program (including Medicare, Medicaid, health-related programs administered by the Indian Health Service, the federal employees health benefits program, military health programs, medical care furnished by the Secretary of Veterans Affairs, and medical services for federal prisoners).